Number of the records: 1
CpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell vaccine confers significant antitumor effects
SYS 0118874 LBL 00000naa--2200000-a-4500 005 20250607154950.0 008 151209c2015----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 242 10
$a CpG oligodeoxynukleotid 1826 v kombinácii s vakcínou rádiorezistentných nádorových buniek dodáva výrazné protinádorové účinky $y slo 245 10
$a CpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell vaccine confers significant antitumor effects / $c X.B. Zhuang ... [et al.] 300 $b ilustr., grafy, obr., tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d018827 $a Lewisov pľúcny karcinóm $x imunológia $x terapia $x rádioterapia $2 mesh 650 12
$7 sllk_us_auth*d007167 $a imunoterapia $2 mesh 650 12
$7 sllk_us_auth*d019496 $a vakcíny protinádorové $x imunológia $2 mesh 650 22
$7 sllk_us_auth*d009838 $a oligodeoxyribonukleotidy $x farmakológia $x imunológia $2 mesh 650 22
$7 sllk_us_auth*d014409 $a faktor nekrotizujúci nádory, alfa $x krv $2 mesh 650 22
$7 sllk_us_auth*d016753 $a interleukín-10 $x krv $2 mesh 650 22
$7 sllk_us_auth*d061026 $a receptor programovanej bunkovej smrti 1 $2 mesh 650 22
$7 sllk_us_auth*d017209 $a apoptóza $2 mesh 650 22
$7 sllk_us_auth*d013534 $a prežívanie $2 mesh 650 22
$7 sllk_us_auth*d051379 $a myši $9 C $2 mesh 700 1-
$7 sllk_us_auth*0037968 $a Zhuang, X.B. $u Departmen of Oncology, Jinshan Hospital, Medical Center of Fudan University, Longhang Road, Jinshan District, Shanghai, China $4 aut 773 0-
$7 nnas $w sllk_us_cat*0118585 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2015 $g Vol. 62, no. 6 (2015), s. 905-913
Number of the records: 1